News

Service eases the management of domestic US shipments to trading partners and patients

Vaccine trials will continue without a clear path forward

KoolTemp GTS Instant avoids use--and cost--of refrigerants

Whole blood use is declining while plasma-derived product consumption rises

Annual specialty-distribution study focuses trend in oncology, chronic diseases

More executional capabilities derive from affiliation with parent, inVentiv Health

Company uses online media to promote fill rates by over 50%

$296-million bid makes it the 'stalking horse' buyer in Dendreon auction

Roughly 40% are for rare diseases; PD-1 oncolytics capture industry attention

'Stay tuned' for interactions directly with pharma companies, says CEO Jeff Tangney

So long WAG, hello to WBA as pharma manufacturers look at a consolidating buyer landscape

Pharmacists' ranking, continuing a two-year decline, is now neck-and-neck with doctors

Express Scripts touts a 'fundamental change' in drug pricing; others would call it negotiating a discount

Acquisition builds on Dohmen's rare-disease business

Poltraf acquisition adds to a network of 14 facilities serving Eastern and Western Europe

Will formularies become a consumer's concern for healthcare provision?

The broad changes taking place in the pharma supply chain this year are a relevant focus for the annual conference and exhibition

FDA enforcement delay to May 1 isn't slowing down project work

Company hires Kevin O'Donnell, cold chain expert, to build out its Biologistex shipping service

Cloud computing opens a new array of benefits--and challenges--to data-sharing

Identity Management

Persistent drug shortages are mostly attributable to manufacturing quality problems, but the economics of low-margin generic manufacturing challenge the industry

When state and federal governments are involved, prices and reimbursements have both regulatory and financial consequences

Outsourced field sales is becoming only part of what CSOs are offering their pharma clients

Publicis Touchpoint Solutions does a deal with Cegedim Relationship Management

Internal compliance reviews are not enough; life sciences companies need to assess their third-party business partners